Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramana, K. V.
Right arrow Articles by Srivastava, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramana, K. V.
Right arrow Articles by Srivastava, S. K.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:818-829, 2005
© 2005 by the American Diabetes Association, Inc.

Requirement of Aldose Reductase for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells

Kota V. Ramana1, Brian Friedrich1, Ravinder Tammali1, Matthew B. West2, Aruni Bhatnagar2, and Satish K. Srivastava1

1 Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, Texas
2 Division of Cardiology, Department of Medicine, University of Louisville, Louisville, Kentucky

Activation of protein kinase C (PKC) has been linked to the development of secondary diabetes complications. However, the underlying molecular mechanisms remain unclear. We examined the contribution of aldose reductase, which catalyzes the first, and the rate-limiting, step of the polyol pathway of glucose metabolism, to PKC activation in vascular smooth muscle cells (VSMCs) isolated from rat aorta and exposed to high glucose in culture. Exposure of VSMCs to high glucose (25 mmol/l), but not iso-osmotic mannitol, led to an increase in total membrane-associated PKC activity, which was prevented by the aldose reductase inhibitors tolrestat or sorbinil or by the ablation of aldose reductase by small interfering RNA (siRNA). The VSMCs were found to express low levels of sorbitol dehydrogenase, and treatment with the sorbitol dehydrogenase inhibitor CP-166572 did not prevent high-glucose-induced PKC activation. Stimulation with high glucose caused membrane translocation of conventional ({alpha}, ß1, ß2, and {gamma}) and novel ({delta} and {varepsilon}) isoforms of PKC. Inhibition of aldose reductase prevented membrane translocation of PKC-ß2 and -{delta} and delayed the activation of PKC-ß1 and -{varepsilon}, whereas membrane translocation of PKC-{alpha} and -{gamma} was not affected. Treatment with tolrestat prevented phosphorylation of PKC-ß2 and -{delta}. High glucose increased the formation of diacylglycerol (DAG) and enhanced phosphorylation of phospholipase C-{gamma}1 (PLC-{gamma}1). Inhibition of aldose reductase prevented high glucose-induced DAG formation and phosphorylation of PLC-{gamma}1 and PLC-ß2 and -{delta}. Inhibition of phospholipid hydrolysis by D609, but not by the synthetic alkyl-1-lysophospholipid 1-O-octadecyl-2-O-methyl-rac-glycerophosphocholine, or edelfosine, prevented DAG formation. Treatment with sorbinil decreased the levels of reactive oxygen species in high-glucose-stimulated VSMCs. Hence, inhibition of aldose reductase, independent of sorbitol dehydrogenase, appears to be effective in diminishing oxidative stress and hyperglycemic changes in signaling events upstream to the activation of multiple PKC isoforms and PLC-{gamma}1 and may represent a useful approach for preventing the development of secondary vascular complications of diabetes.

Address correspondence and reprint requests to Satish K. Srivastava, Department of Human Biological Chemistry and Genetics, 6.644 Basic Science Building, University of Texas Medical Branch, Galveston, Texas, 77555-0647. E-mail: ssrivast{at}utmb.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
U. C. S. Yadav, S. K. Srivastava, and K. V. Ramana
Aldose Reductase Inhibition Prevents Endotoxin-Induced Uveitis in Rats
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4634 - 4642.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava
Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth
Endocrinology, September 1, 2007; 148(9): 4371 - 4384.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Pladzyk, A. B. M. Reddy, U. C. S. Yadav, R. Tammali, K. V. Ramana, and S. K. Srivastava
Inhibition of Aldose Reductase Prevents Lipopolysaccharide-Induced Inflammatory Response in Human Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5395 - 5403.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. V. Ramana, A. A. Fadl, R. Tammali, A. B. M. Reddy, A. K. Chopra, and S. K. Srivastava
Aldose Reductase Mediates the Lipopolysaccharide-induced Release of Inflammatory Mediators in RAW264.7 Murine Macrophages
J. Biol. Chem., November 3, 2006; 281(44): 33019 - 33029.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. V. Ramana, M. S. Willis, M. D. White, J. W. Horton, J. M. DiMaio, D. Srivastava, A. Bhatnagar, and S. K. Srivastava
Endotoxin-Induced Cardiomyopathy and Systemic Inflammation in Mice Is Prevented by Aldose Reductase Inhibition
Circulation, October 24, 2006; 114(17): 1838 - 1846.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Tammali, K. V. Ramana, S. S. Singhal, S. Awasthi, and S. K. Srivastava
Aldose Reductase Regulates Growth Factor-Induced Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Colon Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9705 - 9713.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Nobe, M. Miyatake, T. Sone, and K. Honda
High-Glucose-Altered Endothelial Cell Function Involves Both Disruption of Cell-to-Cell Connection and Enhancement of Force Development
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 530 - 539.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. V. Ramana, A. Bhatnagar, S. Srivastava, U. C. Yadav, S. Awasthi, Y. C. Awasthi, and S. K. Srivastava
Mitogenic Responses of Vascular Smooth Muscle Cells to Lipid Peroxidation-derived Aldehyde 4-Hydroxy-trans-2-nonenal (HNE): ROLE OF ALDOSE REDUCTASE-CATALYZED REDUCTION OF THE HNE-GLUTATHIONE CONJUGATES IN REGULATING CELL GROWTH
J. Biol. Chem., June 30, 2006; 281(26): 17652 - 17660.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Kaiserova, S. Srivastava, J. D. Hoetker, S. O. Awe, X.-L. Tang, J. Cai, and A. Bhatnagar
Redox Activation of Aldose Reductase in the Ischemic Heart
J. Biol. Chem., June 2, 2006; 281(22): 15110 - 15120.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar
Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.
Diabetes, April 1, 2006; 55(4): 901 - 910.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.